KIDS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
OrthoPediatrics Corp (KIDS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company shows promising growth in revenue and improving financial metrics, the technical indicators are bearish, and the stock is likely to decline in the short term. The lack of positive trading signals and recent news further supports a cautious approach.
The MACD is below 0 and negatively contracting, RSI is neutral at 35.729, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level of 16.419, with resistance at 17.58. Overall, the technical outlook is bearish.
Hedge funds have increased their buying activity by 114.29% over the last quarter. Analysts have initiated coverage with Buy ratings and price targets of $23-$24, citing the company's leadership in pediatric orthopedics and potential for sustained revenue growth.
The stock has a 70% probability of declining by -1.27% in the next day, -3.97% in the next week, and -6.59% in the next month. Technical indicators are bearish, and no recent news or significant insider activity has been reported. Congress trading data is also unavailable.
In Q3 2025, revenue increased by 12.23% YoY to $61.25M. Net income improved by 48.67% YoY to -$11.77M, and EPS increased by 47.06% YoY to -0.5. Gross margin rose slightly to 73.92%. While financials are improving, the company is still not profitable.
Analysts from TD Cowen and Canaccord have initiated Buy ratings with price targets of $23-$24, highlighting the company's strong position in pediatric orthopedics and potential for low-double-digit revenue growth. Recent guidance updates have de-risked the stock, leaving room for upside.
